T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro

European Journal of Immunology

Volumn 30, Issue 5, 2000, Pages 1385-1393

  Vecchiarelli, Anna ^a   Retini, Cinzia ^a   Pietrella, Donatella ^a   Monari, Claudia ^a   Kozel, Thomas R ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

CD40 CD40 ligand; Cryptococcus neoformans; Monocyte; T cell

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; NITRIC OXIDE;

ANTIGEN PRESENTING CELL; ARTICLE; CELL CONTACT; CELL INTERACTION; CELL KILLING; COCULTURE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD40 LIGAND; CELLS, CULTURED; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-1; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MONOCYTES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034073854     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200005)30:5<1385::AID-IMMU1385>3.0.CO;2-K     Document Type: Article

References (44)

1. Smith, C. A., Davis, T., Andersen, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D. and Goodwin, R. G., A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990. 248: 1019-1023.
2. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
3. Hasbold, J., Johnson, I. C., Atkins, C. J., Clark, B. A. and Klaus, G. G., Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 1994. 24: 1835-1842.
4. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., MacDuff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein, K. H., Cosman, D. and Spriggs, M. K., Molecular and biological characterization of a murine ligand for CD40. Nature 1992. 357: 80-82.
5. Hollensbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch, A. S., Noelle, R. J., Stamenkovic, I., Lendbetter, J. A. and Aruffo, A., The human T cell antigen CD40L, a member of TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of CD40L with B cell co-stimulatory activity. EMBO J. 1992. 11: 4313-4321.
6. Peitsch, M. C. and Jongeneel, C. V., A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 1993. 5: 233-238.
7. + T cells. J. Immunol. 1993. 151: 2497-2510.
8. Janeway Jr., C. A. and Bottomly, K., Signals and signs for lymphocyte responses. Cell 1994. 76: 275-285.
9. Jenkins, M. K., The ups and downs of T cell costimulation. Immunity 1994. 1: 443-446.
10. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F. and Saeland, S., The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994. 12: 881-922.
11. - T cell contact-dependent activation of monocyle interleukin-1 synthesis. Eur. J. Immunol. 1994. 24: 3148-3154.
12. Kiener, P. A., Moran-Davis, P., Rankin, B. M., Aruffo, A. F. and Hollenbaugh, D., Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 1995. 155: 4917-4925.
13. Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M. and Delespesse, G., Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 1995. 25: 1125-1128.
14. Stout, R., Suttles, J., Xu, J., Grewal, I. and Flavell, R., Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 1996. 156: 8-11.
15. Scott, P., IL-12: initiation cytokine for cell-mediated immunity. Science 1993. 260: 496-497.
16. Trinchieri, G., Interleukin 12 and its role in the generation of Th1 cells, Immunol. Today 1993. 14: 335-338.
17. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonite, R., Wolf, S. F. and Trinchieri, G., Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 1992. 176: 1387-1398.
18. Coutelier, J. P., Van Broeck, J. and Wolf, S. F., Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 1995. 69: 1955-1958.
19. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukuda, Y. and Hattori, K., Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995. 378: 88-91.
20. Romani, L., Puccetti, P. and Bistoni, F., Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 1997. 10: 611-636.
21. Sartori, A., Ma, X., Gri, G., Showe, L., Benjamin, D. and Trinchieri, G., Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells. Methods 1997. 22: 116-127.
22. Retini, C., Casadevall, A., Pietrella, D., Monari, C., Palazzetti, B. and Vecchiarelli, A., Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans. J. Immunol. 1999. 162: 1618-1623.
23. Decken, K., Kohler, G., Palmer-Lehmann K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K. and Alber, G., Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 1998. 66: 4994-5000.
24. Cherniak, R., Reiss, E., Slodki, M. E., Plattner, R. D. and Blumer, S. O., Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans. Mol. Immunol. 1980. 17: 1025-1032.
25. Bhattacharjee, A. K., Bennett, J. E. and Glaudemans, C. P. J., Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 1984. 6: 619-624.
26. Vecchiarelli, A., Pietrella, D., Dottorini, M., Monari, C., Retini, C., Todisco, T. and Bistoni, F., Encapsulation of Cryptococcus neoformans regulates fungicidal activity and antigen presentation process in human alveolar macrophages. Clin. Exp. Immunol. 1994. 98: 217-223.
27. Kozel, T. R., Non-encapsulated variant of Crypfococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect. Immun. 1977. 16: 99-106.
28. Kozel, T. R. and Hermerath, C. A., Binding of cryptococcal polysaccharide to Cryptococcus neoformans. Infect. Immun. 1984. 43: 879-886.
29. Levitz, S. M. and North, E. A., Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells by Cryptococcus neoformans. J. Med. Vet. Mycol. 1997. 35: 229-236.
30. Chan, E. D., Winston, B. W., Uh, S. T., Wynes, M. W., Rose, D. M. and Riches, D.W., Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 1999. 162: 415-422.
31. Soong, L., Xu, J., Grewal, I. S., Kima, P., Sun, J., Longley Jr., B. J., Ruddle, M. H., McMohan-Pratt, D. and Flavell, R. A., Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonesis infection. Immunity 1996. 4: 263-274.
32. Yang, Y. and Wilson, J. M., CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996. 273: 1862-1864.
33. Vecchiarelli, A., Monari, C., Retini, C., Pietrella, D., Palazzetti, B., Pitzurra, L. and Casadevall, A., Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes. Eur. J. Immunol. 1998. 28: 114-121.
34. + T lympho-cytes generates a costimulatory signal that up-regulates IL-4 synthesis. J. Immunol. 1996. 156: 3133-3140.
35. Young, B. J. and Kozel, T. R., Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 1993. 61: 2966-2972.
36. Laxalt, K. A. and Kozel, T. R., Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 1979. 26: 435-440.
37. Grewal, I. S., Xu, J. and Flavell, R. A., Impairment of antigen specific T-cell priming in mice lacking CD40 ligand. Nature 1995. 378: 617-619.
38. Albina, J. E., On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukoc. Biol. 1995. 58: 643-649.
39. Houpt, D. C, Pfrommer, G. S. T., Young, B. J., Larson, T. A. and Kozel, T. R., Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 1994. 62: 2857-2864.
40. Cherniak, R., Reiss, E. and Turner, S. H., A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr. Res. 1982. 103: 239-250.
41. Feldmesser, M. and Casadevall, A., Effect of serum lgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonoary infection. J. Immunol. 1997. 158: 790-799.
42. Vecchiarelli, A., Dottorini, M., Pietrella, D., Monari, C., Retini, C., Todisco, T. and Bistoni, F., Role of alveolar macrophages as antigen presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 1994. 11: 130-137.
43. Vecchiarelli, A., Retini, C., Monari, C. and Casadevall, A., Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T cell proliferation. Infect. Immun. 1998. 66: 1244-1247.
44. Retini, C., Vecchiarelli, A., Monari, C., Bistoni, F. and Kozel, T. R., Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect. Immun. 1998. 66: 664-669.